Ricin Toxin Hits a Retrograde Roadblock  by Seaman, Matthew N.J. & Peden, Andrew A.
enzyme USP5, which selectively cleaves 
unanchored chains (Figure 1A; Reyes-
Turcu et al., 2006), destroyed the abil-
ity of chains released from RIG-I CARD 
domains to promote pathway activation. 
Second, these chains were charged by 
the E1 ubiquitin-activating enzyme, which 
requires a free C-terminal glycine found in 
unanchored ubiquitin chains for charging.
The new work of Zeng et al. establishes 
a model in which RIG-I first senses a viral 
infection by binding to viral RNA through 
its RNA helicase domain, thereby expos-
ing the tandem N-terminal CARD domains 
(Figure 1B). The exposed CARD domains 
then associate with unanchored K63-
linked ubiquitin chains, thereby facilitating 
recognition of MAVS and activation of the 
IRF3 pathway. Although Zeng et al. (2010) 
convincingly demonstrate that unanchored 
K63-linked ubiquitin chains activate RIG-I, 
the underlying mechanism remains to be 
elucidated. As the CARD domain of MAVS 
cannot bind to ubiquitin directly, one pos-
sibility is that binding of ubiquitin to RIG-I 
reveals a surface within the RIG-I CARD 
domains that then interacts with MAVS. 
The origin and abundance of the unan-
chored chains also remains a mystery, 
although Zeng and coworkers provide 
data implicating TRIM25. It remains pos-
sible that a K63-linked ubiquitin chain is 
constructed on RIG-I itself (or on another 
substrate), and that this chain is then 
selectively liberated through the action 
of an unknown deubiquitinating enzyme 
(Figure 1). Because introduction of the RIG 
CARD domains into cells is sufficient to 
activate the IRF3 pathway in the absence 
of a viral RNA trigger, it appears that unan-
chored chains are not limiting within the 
cell. Further, the authors estimate, based 
on the quantity of chains purified with 
RIG-I CARD domains, that there may be 
as many as 6000 unanchored K63-linked 
chains per cell. Although viral infection may 
alter the abundance of unanchored chains, 
it seems plausible that sufficient unan-
chored chains pre-exist. Thus, once trig-
gered by viral RNA, the downstream cas-
cade may be immediately initiated without 
an additional regulatory step. The authors 
estimate that RIG-I can sense less than 20 
molecules of viral RNA or K63-linked ubiq-
uitin chains, making it an exquisite sensor 
of viral infection. The powerful in vitro sys-
tem developed and improved by Zeng et 
al. sets the stage for a more comprehen-
sive analysis of how ubiquitin chains work 
with RIG-I to protect cells against foreign 
invaders and whether unanchored ubiq-
uitin chains are involved in other signaling 
pathways. The answer to these questions 
may just be in the CARDs.
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To inhibit protein synthesis and induce cell death, plant ricin toxin and bacterial Shiga toxins enter 
the cell through the endocytic and retrograde secretory pathways. Stechmann et al. (2010) now 
identify two small-molecule inhibitors that selectively block endosome-to-Golgi retrieval of ricin 
and Shiga toxins and protect mice from ricin’s deadly effects.The plant toxin ricin and the bacte-
rial Shiga toxins are among the most 
toxic compounds known to man. 
Shiga toxins, produced by patho-
genic Escherichia coli and Shigella 
dysenteriae, cause dysentery in mil-
lions of people around the world every 
year; and, ricin, produced by the cas-
tor bean (Ricinus communis), gained 222 Cell 141, April 16, 2010 ©2010 Elsevier notoriety when it was used to assas-
sinate the Bulgarian journalist Georgi 
Markov in 1978. There are currently 
no known antidotes to Shiga toxin or 
ricin, and the potential use of ricin in 
a bioterror attack is of major concern. 
In this issue of Cell, Stechmann et al. 
(2010), now identify two small mol-
ecules that protect cells against Shiga Inc.toxin or ricin by blocking the transport 
of the toxins from endosomes to the 
Golgi apparatus.
Shiga toxin and ricin are members of 
the AB chain toxins, which contain two 
protein subunits (Figure 1). The B chain 
mediates entry into the cell by binding 
to a surface receptor, and the A chain 
inhibits protein synthesis by modifying 
figure 1. Trafficking of AB chain Toxins
(Left) AB chain toxins, such as ricin and Shiga toxin, enter mammalian cells through both clathrin-de-
pendent and clathrin-independent endocytosis. The toxins are then transported from endosomes to the 
Golgi network via a section of the secretory pathway (black arrows), called the retrograde pathway (red 
and black arrows), which requires the retromer complex. Ultimately, the toxins reach the endoplasmic 
reticulum (ER), where the A chain is cleaved from the B chain. The A chain then enters the cytoplasm, 
where it induces cell death by inhibiting protein synthesis. 
(Right) Two compounds, Retro-1 and Retro-2, selectively inhibit the endosome-to-Golgi retrieval of the 
AB chain toxins (Stechmann et al., 2010), but they do not affect the retrograde trafficking of many en-
dogenous proteins, such as CIMPR (cation-independent mannose-6-phosphate receptor). This suggests 
that Retro-1 and Retro-2 probably act downstream of the retromer complex. Retro-1 and Retro-2 perturb 
the localization of the SNARE proteins syntaxin 5 and (to a lesser extent) syntaxin 6, which mediate 
vesicle fusion in the Golgi network.ribosomes in the cytoplasm. Shiga toxin 
and ricin both enter the cell by clathrin-
dependent and clathrin-independent 
endocytosis, which delivers the toxins to 
early endosomes (Figure 1) (Spooner et 
al., 2006). Next, the toxins escape from 
the endocytic system and are delivered 
to the Golgi apparatus by the endosome-
to-Golgi retrieval pathway. Finally, the 
toxins reach the endoplasmic reticulum 
(ER) via the retrograde pathway, where 
the A chains enter the cytoplasm to exert 
their toxic effects on protein synthesis.
Understanding the mechanisms that 
govern the uptake and delivery of the AB 
chain toxins is of great interest, not only for 
the development of therapeutics against 
these toxins, but also because the B sub-unit is a useful biochemical tool for inves-
tigating the endocytic pathway. When 
expressed as a recombinant protein, the B 
chain traffics through the cell using essen-
tially the same mechanism as endogenous 
cellular proteins, including the lysosomal 
hydrolase receptor CIMPR (cation-inde-
pendent mannose-6-phosphate receptor) 
and the Golgi membrane protein TGN46. 
For example, endosome-to-Golgi retrieval 
of CIMPR (Seaman, 2004) and Shiga toxin 
(Bujny et al., 2007; Popoff et al., 2007) both 
require the retromer complex, an endo-
somal protein complex that sorts cargo 
into tubules (Figure 1).
Using a high-throughput approach 
to screen over 16,000 small molecules, 
Stechmann et al. (2010) now identify two Cell 1compounds, Retro-1 and Retro-2, that 
protect HeLa cells and human pulmonary 
epithelial cells against ricin-mediated cell 
death in vitro. The authors find that the 
compounds do not inhibit the binding 
of ricin to the cell or its catalytic activ-
ity. However, both Retro-1 and Retro-2 
do protect HeLa cells against the inhibi-
tion of protein synthesis by Shiga toxin. 
Because ricin and Shiga toxin use essen-
tially identical pathways to traverse the 
cell, the authors hypothesized that the 
protective effects of Retro-1 and Retro-2 
probably occur during trafficking of the 
toxins from the cell surface to the ER.
To test this hypothesis, the authors 
used an immunofluorescence assay with 
the Shiga toxin B chain conjugated to 
a fluorescent tag. They found that both 
Retro-1 and Retro-2 specifically block 
the delivery of toxin from endosomes to 
the Golgi complex but do not affect other 
trafficking pathways, such as endocyto-
sis or the secretory pathway (Figure 1). 
Most surprisingly, Retro-1 and Retro-2 
appear to have no effect on other pro-
teins that traffic between endosomes 
and the Golgi network, including CIMPR 
and TGN46. This implies that, at a par-
ticular point in the endosome-to-Golgi 
retrieval pathway, Shiga toxin B chain 
may be sorted away from other mem-
brane proteins, such as CIMPR and 
TGN46. This separation likely occurs late 
in the endosome-to-Golgi pathway after 
protein-sorting complexes, such as ret-
romer, have performed their function.
To identify the specific targets of the 
Retro-1 and Retro-2 compounds, Stech-
mann and colleagues characterized the 
cellular localization of 26 proteins pres-
ent in either the endocytic pathway or 
the Golgi. They found that Retro-1 and 
Retro-2 altered the location of only two 
of these factors, the SNARE proteins syn-
taxin 5 and syntaxin 6. SNAREs are small 
(14–40 kDa) proteins containing coiled-
coil motifs that associate with intracel-
lular membranes to mediate the docking 
and fusion of transport vesicles. There 
are 38 SNAREs encoded in the human 
genome, with each SNARE localized to a 
defined set of membranes and responsi-
ble for a specific set of membrane fusion 
reactions (Bock et al., 2001). Syntaxin 6, 
syntaxin 16, and syntaxin 5, along with 
vti1a, VAMP3, VAMP4, Ykt6, GS15, and 
GS28, are known to be needed for the 41, April 16, 2010 ©2010 Elsevier Inc. 223
transport of Shiga toxin from endosomes 
to the Golgi apparatus, with depletion of 
syntaxin 5 providing the best protection 
against Shiga toxin (Mallard et al., 2002; 
Tai et al., 2004; Amessou et al., 2007).
Syntaxin 5 is localized primarily to 
the side of the Golgi that receives bio-
synthetic traffic from the ER (i.e., the cis 
side), but its localization extends through 
the Golgi toward the trans side (Fig-
ure 1; Hay et al., 1998); hence, syntaxin 
5 is likely to function at multiple points 
between the Golgi and the ER. Therefore, 
the passage of ricin and Shiga toxin to 
their destination at the ER may be more 
sensitive to treatments that affect func-
tion and/or localization of syntaxin 5 than 
the retrieval of, for example, the CIMPR, 
which is delivered to the trans-Golgi.
How do Retro-1 and Retro-2 alter the 
localization of syntaxin 5? Stechmann et 
al. show that in cells treated with these 
small molecules, syntaxin 5 (and to a 
lesser extent syntaxin 6) relocates from 
the Golgi apparatus to small vesicles in 
the cytoplasm, a step that appears to be 
specific for these SNARE proteins. How-
ever, exactly where Retro-1 and Retro-2 224 Cell 141, April 16, 2010 ©2010 Elsevier In
Biological rhythms, from the beat-
ing of hearts to the flashing of fireflies, 
are driven by regulatory circuits called 
oscillators. The frequency of most bio-
logical oscillators—the heart rate, for 
example—can be adjusted by outside 
signals, allowing coordination of a peri-
odic event with other events or with 
changes in the environment. Some-
times one oscillator is synchronized 
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The cell divides in a series of dis
now propose that cell-cycle even
lator, based on cyclin-dependen
individual events.act in the retrograde trafficking pathway is 
still not known. It is also unclear whether 
the relocalization of syntaxin 5 directly 
causes the block in endosome-to-Golgi 
transport of ricin and Shiga toxins or 
simply results from the inhibition of this 
pathway. Further, it will be important to 
determine if and how Retro-1 and Retro-2 
affect the ability of these SNARE proteins 
to drive membrane fusion.
In a key experiment, Stechmann and 
coworkers show that Retro-2 protects 
mice from a lethal dose of ricin. To achieve 
this effect, however, Retro-2 had to be 
administered prior to ricin exposure, which 
may preclude the use of Retro-2 in treating 
individuals already exposed to ricin. Nev-
ertheless, this result suggests that it may 
be possible to protect against ricin expo-
sure or to treat Shigella infection with com-
pounds that selectively block the transport 
of AB chain toxins in the endosome-to-
Golgi pathway. In addition, the toxin inhibi-
tors identified by Stechmann et al. will be 
useful tools for unraveling the mechanistic 
details of endosome-to-Golgi transport 
of both endogenous proteins and toxic 
intruders.c.
with another—as in the well-known case 
of our body’s circadian rhythm, which is 
entrained to the light-dark cycle of the 
environment. In this issue of Cell, Lu 
and Cross (2010) take the problem of 
oscillator control into rich new territory. 
They provide evidence that a series of 
oscillators is governed by a single mas-
ter oscillator to control the rhythms of 
the cell division cycle.
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15, 4011–4022.Orderly progression through the cell 
cycle is guided by cyclin-dependent 
kinases (Cdks) in association with oscil-
lating cyclin subunits (Morgan, 2007). 
We know a great deal about the regula-
tors that generate the ups and downs of 
Cdk activity, but we have only a minimal 
understanding of how Cdks trigger cell-
cycle events in the correct order. One 
source of order can be found in “check-
iding cell
ific order. Lu and Cross (2010) 
ystem in which a master oscil-
ripheral oscillators controlling 
